Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

AMN Healthcare (AMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates


For the quarter ended March 2025, AMN Healthcare Services (AMN) reported revenue of $689.53 million, down 16% over the same period last year. EPS came in at $0.45, compared to $0.97 in the year-ago quarter.

The reported revenue represents a surprise of +2.72% over the Zacks Consensus Estimate of $671.3 million. With the consensus EPS estimate being $0.19, the EPS surprise was +136.84%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how AMN Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Physician and leadership solutions - Days Filled: 51.34 million versus the two-analyst average estimate of 51.95 million.
  • Physician and leadership solutions - Revenue per day filled: $2.74 million versus $2.63 million estimated by two analysts on average.
  • Revenue- Physician and leadership solutions: $174.07 million versus the four-analyst average estimate of $171.10 million. The reported number represents a year-over-year change of -7.8%.
  • Revenue- Nurse and allied solutions: $413.26 million versus the four-analyst average estimate of $397.20 million. The reported number represents a year-over-year change of -20.4%.
  • Revenue- Technology and workforce solutions: $102.21 million versus $103 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -9.4% change.
  • Segment operating income- Nurse and allied solutions: $32.24 million versus $30.79 million estimated by two analysts on average.
  • Segment operating income- Technology and workforce solutions: $35.25 million compared to the $37.97 million average estimate based on two analysts.
  • Segment operating income- Physician and leadership solutions: $14.46 million versus $17.29 million estimated by two analysts on average.
View all Key Company Metrics for AMN Healthcare here>>>

Shares of AMN Healthcare have returned -5.3% over the past month versus the Zacks S&P 500 composite's +11.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
AMN Healthcare Services Inc (AMN): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Legal notice

Comments